Why Cognizant Technology Solutions (CTSH) Stock Is Up Today

Cognizant Technology Solutions (CTSH) is up 6.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued investor optimism around Cognizant’s stronger second-quarter results, higher full-year adjusted EPS outlook, and growing evidence that its AI-focused strategy is translating into larger deals and improving margins. This could also reflect ongoing support from the company’s sizable 2026 buyback plan, which has reinforced the shareholder-return story.

Details:

Cognizant’s second-quarter 2026 revenue rose 4.5% year over year to $5.48 billion, while adjusted operating margin improved to 16.0% and adjusted EPS increased to $1.37.

The company raised its full-year 2026 adjusted EPS guidance to $5.70 to $5.82, while maintaining its margin outlook and forecasting constant-currency revenue growth of 4.0% to 5.5%.

Management highlighted AI-related momentum, including more than 8,000 AI engagements, an expanded Google Cloud partnership, and a new U.K. tax agency contract valued at more than $250 million over the life of the deal.

An SEC filing in May showed Cognizant increased its repurchase authorization by $2 billion and lifted its 2026 buyback target to $2 billion, which can help support sentiment around the shares.

Sources:

Cognizant, SEC, The Motley Fool

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CTSH Insider Trading Activity

$CTSH insiders have traded $CTSH stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:

JATIN P DALAL (Chief Financial Officer) sold 12,000 shares for an estimated $669,168
JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) sold 2,500 shares for an estimated $142,625
ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 6 sales selling 895 shares for an estimated $47,817.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CTSH Hedge Fund Activity

We have seen 452 institutional investors add shares of $CTSH stock to their portfolio, and 682 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 14,952,942 shares (+inf%) to their portfolio in Q2 2026, for an estimated $579,127,443
GQG PARTNERS LLC removed 8,116,278 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $497,933,655
SG AMERICAS SECURITIES, LLC added 6,957,414 shares (+4285.9%) to their portfolio in Q2 2026, for an estimated $269,460,644
PZENA INVESTMENT MANAGEMENT LLC added 6,266,810 shares (+30.9%) to their portfolio in Q2 2026, for an estimated $242,713,551
WELLINGTON MANAGEMENT GROUP LLP removed 4,639,888 shares (-95.6%) from their portfolio in Q2 2026, for an estimated $179,702,862
MORGAN STANLEY removed 4,323,996 shares (-32.6%) from their portfolio in Q2 2026, for an estimated $167,468,365
MILLENNIUM MANAGEMENT LLC added 3,925,570 shares (+851.3%) to their portfolio in Q2 2026, for an estimated $152,037,326

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CTSH Congressional Stock Trading

Members of Congress have traded $CTSH stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/13 and 1 sale worth up to $15,000 on 04/14.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CTSH Analyst Ratings

Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Susquehanna issued a "Positive" rating on 05/01/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Wells Fargo issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.

$CTSH Price Targets

Multiple analysts have issued price targets for $CTSH recently. We have seen 13 analysts offer price targets for $CTSH in the last 6 months, with a median target of $70.0.

Here are some recent targets:

Bryan Bergin from TD Cowen set a target price of $47.0 on 06/26/2026
James Faucette from Morgan Stanley set a target price of $44.0 on 06/23/2026
Bryan Keane from Citigroup set a target price of $55.0 on 06/09/2026
Steven Wahrhaftig from Wedbush set a target price of $70.0 on 06/08/2026
Arvind Ramnani from Truist Securities set a target price of $66.0 on 06/01/2026
Dan Dolev from Mizuho set a target price of $68.0 on 05/06/2026
James Friedman from Susquehanna set a target price of $88.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.